Related content

Clinical subtypes in Parkinson’s disease: the impact of MAPT haplotypes

By Battista Maria   Pascale Esterina   Purcaro Carlo   Passarelli Francesca   Passarelli Emanuela   Guglielmi Renzo   Vanacore Nicola   Meco Giuseppe  

Journal of Neural Transmission, Vol. 121, Iss. 4, 2014-04 ,pp. : 353-356

Springer Publishing Company

Access to resources Recommend Favorite

Fabry disease

By  

PRACTICAL NEUROLOGY, Vol. 5, Iss. 2, 2005-04 ,pp. : 110-113

John Wiley & Sons Inc

Access to resources Recommend Favorite

Striatal hand in Parkinson’s disease: the re-evaluation of an old clinical sign

By Spagnolo Francesca   Fichera M.   Bucello S.   Houdayer E.   Baroncini D.   Sarro L.   Leopizzi E.   Impellizzeri M.   Martinelli V.   Leocani L.   Comi G.   Volonté M.  

Journal of Neurology, Vol. 261, Iss. 1, 2014-01 ,pp. : 117-120

Springer Publishing Company

Access to resources Recommend Favorite

Fabry disease in patients with migraine with aura

By Albano Beatrice   Dinia L.   Sette M.   Gandolfo C.   Sivori G.   Finocchi C.  

Neurological Sciences, Vol. 31, Iss. 1, 2010-06 ,pp. : 167-169

Springer Publishing Company

Access to resources Recommend Favorite

The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on α7 nicotinic receptors in hippocampal neurons: Clinical Implications for treatment of Alzheimer's disease

By Popa Rodica   Pereira Edna   Lopes Cristiane   Maelicke Alfred   Albuquerque Edson  

Journal of Molecular Neuroscience, Vol. 30, Iss. 1-2, 2006-02 ,pp. : 227-232

Humana Press, Inc

Access to resources Recommend Favorite